|
Market Closed -
Nasdaq
16:00:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 549.16 USD | +3.07% |
|
+1.38% | +12.71% |
| 10-09 | United Therapeutics Insider Sold Shares Worth $5,075,919, According to a Recent SEC Filing | MT |
| 10-08 | United Therapeutics Insider Sold Shares Worth $5,215,015, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- UTHR Stock
- Consensus United Therapeutics Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
